Cite
HARVARD Citation
Lefebvre, E. et al. (2016). Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment. Clinical and translational science. 9 (3), pp. 139-148. [Online].